The efficacy of daily chlorhexidine bathing for preventing healthcare-associated infections in adult intensive care units

Korean Journal of Internal Medicine

Volumn 31, Issue 6, 2016, Pages 1159-1170

  Huang, Hua Ping ^a   Chen, Bin ^a   Wang, Hai Yan ^a   He, Me ^a  

^a MIANYANG CENTRAL HOSPITAL   (China)

Author keywords

Bathing; Chlorhexidine gluconate; Infection; Intensive care units

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE GLUCONATE; SOAP; CHLORHEXIDINE; TOPICAL ANTIINFECTIVE AGENT;

ARTICLE; BATH; CATHETER ASSOCIATED URINARY TRACT INFECTION; CATHETER INFECTION; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; LENGTH OF STAY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; RASH; SKIN IRRITATION; SYSTEMATIC REVIEW; VANCOMYCIN RESISTANT ENTEROCOCCUS; VENTILATOR ASSOCIATED PNEUMONIA; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; ANTIBIOTIC RESISTANCE; ARTIFICIAL VENTILATION; BLADDER CATHETERIZATION; CATHETER-RELATED INFECTIONS; CHI SQUARE DISTRIBUTION; CROSS INFECTION; DRUG EFFECTS; INFECTION CONTROL; ISOLATION AND PURIFICATION; META ANALYSIS; MICROBIOLOGY; ODDS RATIO; PROCEDURES; RESPIRATORY TRACT INFECTIONS; RISK FACTOR; TRANSMISSION; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

ANTI-INFECTIVE AGENTS, LOCAL; BATHS; CATHETER-RELATED INFECTIONS; CHI-SQUARE DISTRIBUTION; CHLORHEXIDINE; CRITICAL CARE; CROSS INFECTION; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; ODDS RATIO; RESPIRATION, ARTIFICIAL; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; TREATMENT OUTCOME; URINARY CATHETERIZATION; URINARY TRACT INFECTIONS; VANCOMYCIN RESISTANCE; VANCOMYCIN-RESISTANT ENTEROCOCCI;

EID: 84994393202     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2015.240     Document Type: Article

References (40)

1. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. N Engl J Med 2014;370:1198-1208.
2. Bonten MJ. Healthcare epidemiology. Ventilator-associated pneumonia: preventing the inevitable. Clin Infect Dis 2011;52:115-121.
3. Roberts RR, Scott RD 2nd, Hota B, et al. Costs attributable to healthcare-acquired infection in hospitalized adults and a comparison of economic methods. Med Care 2010;48:1026-1035.
4. Lim KS, Kam PC. Chlorhexidine: pharmacology and clinical applications. Anaesth Intensive Care 2008;36:502-512.
5. Popovich KJ, Lyles R, Hayes R, et al. Relationship between chlorhexidine gluconate skin concentration and microbial density on the skin of critically ill patients bathed daily with chlorhexidine gluconate. Infect Control Hosp Epidemiol 2012;33:889-896.
6. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med 2007;167:2073-2079.
7. Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009;37:1858-1865.
8. Holder C, Zellinger M. Daily bathing with chlorhexidine in the ICU to prevent central line-associated bloodstream infections. J Clin Outcomes Manag 2009;16:509-513.
9. Dixon JM, Carver RL. Daily chlorohexidine gluconate bathing with impregnated cloths results in statistically significant reduction in central line-associated bloodstream infections. Am J Infect Control 2010;38:817-821.
10. Evans HL, Dellit TH, Chan J, Nathens AB, Maier RV, Cuschieri J. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg 2010;145:240-246.
11. Popovich KJ, Hota B, Hayes R, Weinstein RA, Hayden MK. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol 2009;30:959-963.
12. Climo MW, Yokoe DS, Warren DK, et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013;368:533-542.
13. Srinivas A, Kaman L, Raj P, et al. Comparison of the efficacy of chlorhexidine gluconate versus povidone iodine as preoperative skin preparation for the prevention of surgical site infections in clean-contaminated upper abdominal surgeries. Surg Today 2015;45:1378-1384.
14. Vernon MO, Hayden MK, Trick WE, et al. Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci. Arch Intern Med 2006;166:306-312.
15. Noto MJ, Domenico HJ, Byrne DW, et al. Chlorhexidine bathing and health care-associated infections: a randomized clinical trial. JAMA 2015;313:369-378.
16. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-269.
17. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
18. Wells GA, Shea B, O’Connell D, et al. The Newcastle-Ot-tawa Scale (NOS) for assessing the quality of nonran-domised studies in meta-analyses [Internet]. Ottawa (ON): Ottawa Hospital Research Institute, c2014 [cited 2016 Jan 26]. Available from: http://www.ohri.ca/programs/clinical_ epidemiology/oxford.asp.
19. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-560.
20. Popovich KJ, Hota B, Hayes R, Weinstein RA, Hayden MK. Daily skin cleansing with chlorhexidine did not reduce the rate of central-line associated bloodstream infection in a surgical intensive care unit. Intensive Care Med 2010;36:854-858.
21. Montecalvo MA, McKenna D, Yarrish R, et al. Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med 2012;125:505-511.
22. Martinez-Resendez MF, Garza-Gonzalez E, Mendo-za-Olazaran S, et al. Impact of daily chlorhexidine baths and hand hygiene compliance on nosocomial infection rates in critically ill patients. Am J Infect Control 2014;42:713-717.
23. Petlin A, Schallom M, Prentice D, et al. Chlorhexidine gluconate bathing to reduce methicillin-resistant Staphylococcus aureus acquisition. Crit Care Nurse 2014;34:17-25.
24. Viray MA, Morley JC, Coopersmith CM, Kollef MH, Fraser VJ, Warren DK. Daily bathing with chlorhexidine-based soap and the prevention of Staphylococcus aureus transmission and infection. Infect Control Hosp Epidemiol 2014;35:243-250.
25. Cassir N, Thomas G, Hraiech S, et al. Chlorhexidine daily bathing: impact on health care-associated infections caused by gram-negative bacteria. Am J Infect Control 2015;43:640-643.
26. Milstone AM, Elward A, Song X, et al. Daily chlorhexidine bathing to reduce bacteraemia in critically ill children: a multicentre, cluster-randomised, crossover trial. Lancet 2013;381:1099-1106.
27. O’Horo JC, Silva GL, Munoz-Price LS, Safdar N. The efficacy of daily bathing with chlorhexidine for reducing healthcare-associated bloodstream infections: a meta-analysis. Infect Control Hosp Epidemiol 2012;33:257-267.
28. Derde LP, Dautzenberg MJ, Bonten MJ. Chlorhexidine body washing to control antimicrobial-resistant bacteria in intensive care units: a systematic review. Intensive Care Med 2012;38:931-939.
29. Munoz-Price LS, Hota B, Stemer A, Weinstein RA. Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long-term acute care hospital. Infect Control Hosp Epidemiol 2009;30:1031-1035.
30. Kassakian SZ, Mermel LA, Jefferson JA, Parenteau SL, Machan JT. Impact of chlorhexidine bathing on hospital-acquired infections among general medical patients. Infect Control Hosp Epidemiol 2011;32:238-243.
31. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
32. Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care 2005;50:725-739.
33. Shi Z, Xie H, Wang P, et al. Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia. Cochrane Database Syst Rev 2013;8:CD008367.
34. Lambert ML, Palomar M, Agodi A, et al. Prevention of ventilator-associated pneumonia in intensive care units: an international online survey. Antimicrob Resist Infect Control 2013;2:9.
35. Klompas M, Speck K, Howell MD, Greene LR, Berenholtz SM. Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta-analysis. JAMA Intern Med 2014;174:751-761.
36. Gould CV, Umscheid CA, Agarwal RK, Kuntz G, Pegues DA; Healthcare Infection Control Practices Advisory Committee. Guideline for prevention of catheter-associated urinary tract infections 2009. Infect Control Hosp Epidemiol 2010;31:319-326.
37. Hooton TM, Bradley SF, Cardenas DD, et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis 2010;50:625-663.
38. Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjer-nberg I, Vaneechoutte M. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 1997;35:2819-2825.
39. Shuman EK, Chenoweth CE. Recognition and prevention of healthcare-associated urinary tract infections in the intensive care unit. Crit Care Med 2010;38(8 Suppl):S373-S379.
40. Cassir N, Papazian L, Fournier PE, Raoult D, La Scola B. Insights into bacterial colonization of intensive care pa-tients’ skin: the effect of chlorhexidine daily bathing. Eur J Clin Microbiol Infect Dis 2015;34:999-1004.